Synchron Brings AI-Powered Brain-Computer Interfaces to Mass Market
Synchron, a pioneer in endovascular brain-computer interfaces (BCIs), has emerged as a leader in the rapidly growing BCI sector. The company’s Stentrode BCI system has shown remarkable potential in clinical trials, enabling patients with ALS, stroke, and spinal cord injuries to control digital devices using neural signals. Strategic partnerships with Apple and NVIDIA have further … Read more